Cancer and Stem Cell Signaling: a Guide to Preventive and Therapeutic Strategies for Cancer Stem Cells

Overview

Journal Stem Cell Rev

Specialty Cell Biology

Date 2007 Sep 18

PMID 17873376

Citations 6

Authors

S Sell

Affiliations

Soon will be listed here.

Citing Articles

Asymmetric Cell Division and Tumor Heterogeneity.

Li Z, Zhang Y, Zhang H, Yang J, Chen Y, Lu H Front Cell Dev Biol. 2022; 10:938685.

PMID: 35859890 PMC: 9289117. DOI: 10.3389/fcell.2022.938685.

Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells.

Zhu Q, Shen Y, Chen X, He J, Liu J, Zu X Onco Targets Ther. 2020; 13:525-540.

PMID: 32021295 PMC: 6970631. DOI: 10.2147/OTT.S224465.

Targeting of Lung Cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin J.

Udoh K, Parte S, Carter K, Mack A, Kakar S Stem Cell Rev Rep. 2019; 15(4):601-611.

PMID: 30835047 PMC: 6626573. DOI: 10.1007/s12015-019-09874-7.

The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.

Klauzinska M, Castro N, Rangel M, Spike B, Gray P, Bertolette D Semin Cancer Biol. 2014; 29:51-8.

PMID: 25153355 PMC: 4252566. DOI: 10.1016/j.semcancer.2014.08.003.

Genomic profiling of tumor initiating prostatospheres.

Duhagon M, Hurt E, Sotelo-Silveira J, Zhang X, Farrar W BMC Genomics. 2010; 11:324.

PMID: 20500816 PMC: 2900264. DOI: 10.1186/1471-2164-11-324.

References

Van de Vijver M . Gene-expression profiling and the future of adjuvant therapy. Oncologist. 2005; 10 Suppl 2:30-4. DOI: 10.1634/theoncologist.10-90002-30. View

Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N . Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol. 2005; 6(10):1038-46. DOI: 10.1038/ni1251. View

Lewis J . Notch signalling and the control of cell fate choices in vertebrates. Semin Cell Dev Biol. 1999; 9(6):583-9. DOI: 10.1006/scdb.1998.0266. View

Libermann T, Zerbini L . Targeting transcription factors for cancer gene therapy. Curr Gene Ther. 2006; 6(1):17-33. DOI: 10.2174/156652306775515501. View

Weissman I . Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000; 100(1):157-68. DOI: 10.1016/s0092-8674(00)81692-x. View

Ikawa M, Tanaka N, Kao W, Verma I . Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy. Mol Ther. 2003; 8(4):666-73. DOI: 10.1016/s1525-0016(03)00240-5. View

Sell S . Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol. 2004; 51(1):1-28. DOI: 10.1016/j.critrevonc.2004.04.007. View

Hanazono Y, Asano T, Ueda Y, Ozawa K . Genetic manipulation of primate embryonic and hematopoietic stem cells with simian lentivirus vectors. Trends Cardiovasc Med. 2003; 13(3):106-10. DOI: 10.1016/s1050-1738(02)00253-0. View

Glinsky G . Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin.... Cell Cycle. 2006; 5(11):1208-16. DOI: 10.4161/cc.5.11.2796. View

10.

Roskoski Jr R . Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor. Biochem Biophys Res Commun. 2005; 338(3):1307-15. DOI: 10.1016/j.bbrc.2005.09.150. View

11.

Kiel M, Yilmaz O, Iwashita T, Yilmaz O, Terhorst C, Morrison S . SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005; 121(7):1109-21. DOI: 10.1016/j.cell.2005.05.026. View

12.

Nickoloff B, Hendrix M, Pollock P, Trent J, Miele L, Qin J . Notch and NOXA-related pathways in melanoma cells. J Investig Dermatol Symp Proc. 2005; 10(2):95-104. DOI: 10.1111/j.1087-0024.2005.200404.x. View

13.

Sell S . Leukemia: stem cells, maturation arrest, and differentiation therapy. Stem Cell Rev. 2006; 1(3):197-205. DOI: 10.1385/SCR:1:3:197. View

14.

Pirollo K, Rait A, Zhou Q, Hwang S, Dagata J, Zon G . Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system. Cancer Res. 2007; 67(7):2938-43. DOI: 10.1158/0008-5472.CAN-06-4535. View

15.

Sell S . Potential gene therapy strategies for cancer stem cells. Curr Gene Ther. 2006; 6(5):579-91. DOI: 10.2174/156652306778520674. View

16.

Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C . Dissecting self-renewal in stem cells with RNA interference. Nature. 2006; 442(7102):533-8. DOI: 10.1038/nature04915. View

17.

Al-Hajj M, Wicha M, Benito-Hernandez A, Morrison S, Clarke M . Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100(7):3983-8. PMC: 153034. DOI: 10.1073/pnas.0530291100. View

18.

Toren A, Bielorai B, Jacob-Hirsch J, Fisher T, Kreiser D, Moran O . CD133-positive hematopoietic stem cell "stemness" genes contain many genes mutated or abnormally expressed in leukemia. Stem Cells. 2005; 23(8):1142-53. DOI: 10.1634/stemcells.2004-0317. View

19.

Druker B, Guilhot F, OBrien S, Gathmann I, Kantarjian H, Gattermann N . Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006; 355(23):2408-17. DOI: 10.1056/NEJMoa062867. View

20.

Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R . Normal and oncogenic forms of the receptor tyrosine kinase kit. Stem Cells. 2004; 23(1):16-43. DOI: 10.1634/stemcells.2004-0117. View